4D Molecular Therapeutics, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Mailing Address 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Phone 5105052680
Fiscal Year End 1231
EIN 473506994
Financial Overview
FY2024 FY
$37K
Revenue
$560.38M
Total Assets
$249.11M
Cash & Equivalents
$-2.98
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 9, 2026 | View on SEC |
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 3 Initial insider ownership report | January 7, 2026 | View on SEC |
| 8-K Current report of material events | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | December 23, 2025 | View on SEC |
| 3 Initial insider ownership report | December 19, 2025 | View on SEC |
| 4 Insider stock transaction report | December 19, 2025 | View on SEC |
| 4 Insider stock transaction report | December 16, 2025 | View on SEC |
| 4 Insider stock transaction report | December 11, 2025 | View on SEC |
Insider Trading
SELL 2 insiders
4 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.